Skip to content
Preprint · OA via OpenAlex

Dissecting the role of alpha-synuclein phosphorylation in Parkinson’s disease

Joana Isabel Silva Rodrigues

New University of Lisbon's Repository (New University of Lisbon) · 2017

Abstract

Parkinson’s disease is the second most common neurodegenerative disorder, characterized by an aggregation of alpha-synuclein in the dopaminergic neurons of the substantia nigra pars compacta and, consequently, neuronal death. Surviving dopaminergic neurons present alpha-synuclein deposits, known as Lewy Bodies. Parkinson’s disease can have sporadic or genetic cause. Parkinson’s disease associated with SNCA, the alpha-synuclein encoding gene, shows an autosomal dominant inheritance pattern. Until now, six SNCA mutations were identified. Alpha-synuclein is prone to suffer several post-translational modifications, critical for its function and structural properties. Phosphorylation is a modification of major importance, since it it’s the modification most commonly found in aggregates; it may play an important role in regulating alpha-synuclein structure, oligomerization and toxicity. However, whether phosphorylation promotes or prevents these properties is still under debate, with distinct cellular models presenting contradictory results. Saccharomyces cerevisiae cells are an established model to study Parkinson’s disease, since it can reproduce several features, such as protein aggregation and cellular toxicity. For this study, multicopy plasmids containing different alpha-synuclein variants fused with GFP under the regulation of a GAL1 promoter were transformed in yeast cells. Effects of phosphorylation at different residues in alpha-synuclein inclusion formation and cell toxicity were evaluated. Furthermore, the six known SNCA mutations (A30P, E46K, H50Q, G51D, A53E and A53T) were characterized regarding inclusion formation, cell toxicity, protein levels, protein clearance, vacuole acidification and ROS production. Evaluation of phosphorylation effects revealed that either blockage or mimic of S129 phosphorylation always overcome the S87 phosphorylation effect, with S129A increasing toxicity, while S129D promotes protection. Regarding tyrosine residues phosphorylation, Y125 phosphorylation blockage impaired protein clearance, increasing its toxicity. Concerning familial mutations, A30P, G51D and A53E aSyn, point to a lower toxicity than WT aSyn, while the H50Q and A53T mutations presented results very similar to WT, and E46K aSyn was the only one who presented higher toxicity. This divergence is probably due to the cellular model used, since yeast cells present a distinct cellular environment than the affected dopaminergic neurons in PD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
Canonical
link ↗
Fetched
2026-10-27 MST

Cite this

APA
Rodrigues, J.I.S. (2017). Dissecting the role of alpha-synuclein phosphorylation in Parkinson’s disease. <em>New University of Lisbon's Repository (New University of Lisbon)</em>. https://openalex.org/W2765890900
Vancouver
Rodrigues JIS. Dissecting the role of alpha-synuclein phosphorylation in Parkinson’s disease. New University of Lisbon's Repository (New University of Lisbon). 2017.
BibTeX
@unpublished{joana2017Dissec, title = {Dissecting the role of alpha-synuclein phosphorylation in Parkinson’s disease}, author = {Joana Isabel Silva Rodrigues}, journal = {New University of Lisbon's Repository (New University of Lisbon)}, year = {2017}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings